Clinical trial participants should have a say in new drug pricing
| 05-18-2017
Clinical trial participants should have a say in new drug pricing. Credit: ranys - PixabayPeople who volunteer to participate in clinical trials of new drugs provide a valuable service to pharmaceutical companies and to the rest of us. In return, I think that they should have a say in how much these drugs will cost when they hit the market. Not only would that honor their service, but it would also provide a patient-centered mechanism to lower the price of new drugs. …
Related Videos
Recommended
Popular
Morning exposure to deep red light improves declining eyesight 11-24-2021 
Targeted drug combination shows unprecedented activity in some… 11-24-2021 
Aspirin linked to increased heart failure risk 11-22-2021 
New findings on bacteria that increase risk of pancreatic cancer 11-24-2021 
Relationship between immune response to influenza and genetic ancestry 11-25-2021